go back

New Jersey rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $13,490 · 10th–90th $135–$30,2000%10%10th90th$13,490Professionalmedian $426,580 · 10th–90th $426,580–$426,5800%50%$426,580$100.0$500.0$2.0K$10.0K$50.0K$200.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Horizon BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$134.90 / $13,489.63 / $30,199.52
Horizon BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$426,579.52 / $426,579.52 / $426,579.52
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$549,540.87 / $549,540.87 / $549,540.87